DRAP directs Searle to recall hydryllin syrup

Aftab Ahmed

Islamabad: The Drug Regulatory Authority of Pakistan (DRAP) has declared hydryllin sugar-free syrup manufactured by the SearlCompany Limited ‘substandard and adulterated’ and directs to recall it from the market.

The DRAP issued a medical product alert that hydryllin syrup is out of quality and prohibited to use for the patients. The doctors had recommended hydryllin syrup for dry cough.

Searl Company Limited produced sugar-free syrup, which was substandard and adulterated. The DRAP declared the product substandard and adulterated. However, the DRAP issued this after following a report from Karachi based laboratory.

The drug regulator had directed the company to recall all the stocks of mentioned batches of product “Hydryllin Sugar-Free Syrup” from the market.

It had also further directed the company to issue directions and alert sales officers, suppliers, and distributors to suspend stocks in the market.

The regulator further asked to issue instructions to the pharmacies, hospitals, point of sales, purchase, and use for the return of suspected stocks of product in question.

Furthermore, DRAP had also directed to submit a compliance report of recall to this division within seven days positively.

The company had produced this product for allergic conditions. The company had recommended the use of Hydryllin syrup to treat runny nose, dry cough, sneezing, watery eyes, itchy nose, itchy throat.  Doctors also recommended hydraulic syrup to treat Patients with metabolic alkalosis as well.